TNF and neuroblastoma: To that end, identifying ‘drug-deliverables’ that selectively disrupt IR-induced NFκB-TNFα feedback signaling and impedes NFκB maintenance could deter NFκB-dependent survival advantage and potentiate RT in NB cure.